• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Facebook
  • X (Twitter)
Get in touch
  • info@hcandersencapital.dk
  • Bredgade 23B, 2. sal
    1260 København K
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Regulatory press release

Photocure ASA: Invitation to presentation of first quarter 2026 financial results

Photocure
Oslo, Norway, 30 April 2026: Photocure ASA (Photocure, PHO: OSE) will announce
the first quarter 2026 financial results on Thursday 7 May 2026 at 08:00 CEST
and will present a live webcast at 14:00 CEST the same day.

The quarterly report and presentation will be published at 08:00 CEST and will
be publicly available at www.photocure.com.

The investor presentation will be streamed live and hosted by Dan Schneider, CEO
and Erik Dahl, CFO. The presentation will be held in English and questions can
be submitted throughout the event. The presentation is scheduled to conclude at
14:45 CEST.

The streaming event is available through
https://qcnl.tv/p/xXUD8ZENOu17GeO0kLRJGQ (https://eur01.safelinks.protection.out
l
ook.com/?url=https%3A%2F%2Fqcnl.tv%2Fp%2FxXUD8ZENOu17GeO0kLRJGQ&data=05%7C02%7CT
H
%40photocure.no%7C9c98dffa222544e7a72708dea52f1c8b%7C0986794f1d6f488980bd853c071
5
d3c1%7C0%7C0%7C639129818977571390%7CUnknown%7CTWFpbGZsb3d8eyJFbXB0eU1hcGkiOnRydW
U
sIlYiOiIwLjAuMDAwMCIsIlAiOiJXaW4zMiIsIkFOIjoiTWFpbCIsIldUIjoyfQ%3D%3D%7C0%7C%7C%
7
C&sdata=U0MqeON103mBP9oE868rFkSjQvXjoG7sg0JiLPiwcSs%3D&reserved=0)

For further information, please contact:

Photocure
Erik Dahl
CFO
Tel: +47 45055000
Email: ed@photocure.com

Priyam Shah
Vice President of Investor Relations
Tel: +17176815072
Email: priyam.shah@photocure.com

Media enquiries:
Geir Bjørlo
Corporate Communications (Norway)
Tel: +47 91540000
Email: geir.bjorlo@corpcom.no

About Photocure
Photocure: The Bladder Cancer Company delivers transformative solutions to
improve the lives of bladder cancer patients. Our unique technology, making
cancer cells glow bright pink, has led to better health outcomes for patients
worldwide. Photocure is headquartered in Oslo, Norway and listed on the Oslo
Stock Exchange (OSE: PHO). For more information, please visit us at
www.photocure.com/news

This information is subject to the disclosure requirements pursuant to section 5
-12 of the Norwegian Securities Trading Act.